Trials / Terminated
TerminatedNCT04459299
CorPath GRX STEMI Study
An Evaluation of Performance of the CorPath® GRX System in Robotic-PCI During Acute STEMI
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 3 (actual)
- Sponsor
- Corindus Inc. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the performance of the CorPath GRX System in Robotic Primary PCI (RPPCI) in the treatment of ST-elevated myocardial infarction (STEMI).
Detailed description
This is a prospective, post-market, single-arm, multi-center, observational study to evaluate the performance of the CorPath GRX System during robotic-PCI for acute ST elevation myocardial infarction (STEMI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Robotic-PCI (CorPath GRX System) | Robotic-PCI for acute ST elevation myocardial infarction (STEMI). |
Timeline
- Start date
- 2020-09-28
- Primary completion
- 2020-11-26
- Completion
- 2020-11-29
- First posted
- 2020-07-07
- Last updated
- 2023-12-20
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04459299. Inclusion in this directory is not an endorsement.